| Lung Squamous Cell Carcinoma studied in …STUDIED_INderived141 of 141show fewer |
|---|
| → studied in | NCT04267848Phase 3 · recruiting Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07489066Phase 2 · recruiting Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05607108Phase 2 · recruiting A Study of ZEN003694 in People With Squamous Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03965689Phase 2 · active not recruiting Testing the Combination of MLN4924 (Pevonedistat), Carboplatin, and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated With Immunotherapy · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04216316Phase 1/Phase 2 · active not recruiting Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831863Phase 3 · not yet recruiting A Study of 7MW3711 Compared With Docetaxel in Advanced Squamous NSCLC After Prior Chemoimmunotherapy · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07147361active not recruiting Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07109726Phase 1/Phase 2 · recruiting A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07217171Phase 1 · recruiting A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07806500Phase 1 · not yet recruiting Phase Ib Study of Oral R01 Monotherapy in Advanced Solid Tumors · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00334815Phase 2 · active not recruiting Combination Chemotherapy, Radiation Therapy, and Bevacizumab in Treating Patients With Newly Diagnosed Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05797168Phase 1/Phase 2 · recruiting Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02955290Phase 1/Phase 2 · active not recruiting CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or Squamous Head and Neck Cancer · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06222489Phase 2 · recruiting Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01386385Phase 1/Phase 2 · active not recruiting Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05256290Phase 1/Phase 2 · active not recruiting Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02186847Phase 2 · completed Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05873686Phase 1 · recruiting A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06403436Phase 1 · completed A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04566432completed Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03110978Phase 2 · active not recruiting Stereotactic Body Radiation Therapy With or Without Nivolumab in Treating Patients With Stage I-IIA or Recurrent Non-small Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03199651NA · recruiting Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06051695Phase 1/Phase 2 · recruiting A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02785952Phase 3 · active not recruiting Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06463665Phase 2 · recruiting Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07618793Phase 2 · not yet recruiting Intermittent Hypoxic Training as Neoadjuvant Therapy for Lung Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07567313Phase 4 · not yet recruiting Stage IV Lung Squamous Cell Carcinoma Treated With or Without Bronchial Artery Chemoembolization After First-line Chemotherapy and Immunotherapy · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05865990Phase 2 · completed HER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal Disease · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04266730Phase 1 · suspended Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07444281Phase 1 · recruiting An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+ Advanced/Metastatic Squamous Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01345851NA · active not recruiting Image-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination Chemotherapy in Treating Patients With Stage II-III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05566223Phase 1/Phase 2 · withdrawn CISH Inactivated TILs in the Treatment of NSCLC · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07392073not yet recruiting Peripheral Blood ETASTs for Predicting Efficacy of Chemoimmunotherapy in NSCLC · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05613413Phase 2 · recruiting A Pilot Phase II Study of Maintenance Cabozantinib Plus Pembrolizumab for Patients With Metastatic Squamous Non-Small Cell Lung Cancer (sqNSCLC) · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07275073Phase 1 · recruiting JMT106 Injection in the Treatment of Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06121505Phase 2 · recruiting Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic Squamous Cell Lung Cancer · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05652868Phase 1 · terminated Clinical Study of Antibody-Drug Conjugate MYTX-011 in Subjects With Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03177291Phase 1 · completed Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05120271Phase 1/Phase 2 · active not recruiting BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05194735Phase 1/Phase 2 · terminated Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01737502Phase 1/Phase 2 · completed Sirolimus and Auranofin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer or Small Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04429542Phase 1 · recruiting Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07038915Phase 2 · withdrawn STRIVE: A Single-arm Phase 2 Study on Treatment of Lung Squamous Cell Carcinoma by Tiragolumab Plus Ivonescimab for Patients Who Progressed on Platinum Doublets and Anti-PD-1/PD-L1 · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05292859completed Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05086692Phase 1/Phase 2 · recruiting A Beta-only IL-2 ImmunoTherapY Study · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05943795Phase 3 · active not recruiting A Clinical Study of SI-B001 Combined With Docetaxel in the Treatment of Non-small Cell Lung Adenocarcinoma and Lung Squamous Cell Carcinoma · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07009925Phase 2 · not yet recruiting Phase II Study of Platinum (Cisplatin/Carboplatin)and Polymeric Micelles Paclitaxel(Pm-Pac) With Ivonescimab in First Line Metastatic Squamous NSCLC. · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04152018Phase 1 · terminated Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors. · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03845296Phase 2 · completed Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05736731Phase 1/Phase 2 · active not recruiting A Study to Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04802876Phase 2 · active not recruiting Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04032704Phase 2 · terminated A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04357873Phase 2 · completed Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06647836enrolling by invitation The Therapeutic Effect of Immunotherapy in Patients With Advanced Lung Squamous Carcinoma · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02264210Phase 2 · completed Icotinib for Completed Resected IB NSCLC With EGFR Mutation · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04944173Phase 2 · withdrawn SCION: SABR and Checkpoint Inhibition of NSCLC · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03198546Phase 1 · recruiting GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 Expression · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06436040unknown Mechanism Study to Investigate Difference in Efficacy of Neoadjuvant Chemoimmunotherapy in Lung Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03866993Phase 3 · completed A Study of Anti-PD-1 AK105 in Patients With Metastatic Squamous Non-small Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06037733NA · recruiting Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06255197recruiting Characteristics, Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06207292NA · unknown Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05984017unknown A Non-interventional Study With Advanced Lung Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05550961recruiting APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02831933Phase 2 · terminated Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal Melanoma · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05127590Phase 1/Phase 2 · unknown RBN-2397 in Combination With Pembrolizumab in Patients With SCCL · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01824901Phase 1/Phase 2 · completed Docetaxel With or Without FGFR Inhibitor AZD4547 in Treating Patients With Recurrent Non-Small Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03373760Phase 2 · completed Durvalumab and Tremelimumab in Treating Patients With Recurrent Stage IV Lung Cancer · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03827850Phase 2 · terminated FGFR Inhibitor in FGFR Dysregulated Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02154490completed Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02766335Phase 2/Phase 3 · completed Lung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00946712Phase 3 · terminated S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05782764Phase 4 · unknown A Study of Endostar Combined With Chemotherapy and Immunotherapy in Lung Squamous Cell Carcinom · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05778253recruiting The Role of ctDNA Testing Plus AI-based Pathology in Resectable LSCC · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05718167Phase 3 · unknown TQB2450 Injection Combined With Chemotherapy Followed by Sequential Combination With Anlotinib Hydrochloride Capsule for First-line Treatment of Advanced Squamous Non-small Cell Lung Cancer. · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04261725completed Prevalence of EGFR Mutations in epidermoïd Bronchopulmonary Cancers in Réunion Island · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03041181Phase 2 · terminated Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02920476Phase 2 · completed TAS-102 in Previously Treated Unresectable or Metastatic Squamous Cell Lung Carcinoma (UF-STO-LUNG-003) · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05395611unknown Exhaled Breath Particles in Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02417701Phase 2 · completed Sapanisertib in Treating Patients With Stage IV or Recurrent Lung Cancer · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05207904Phase 2 · unknown Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced Squamous NSCLC With Brain Metastases · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04025424unknown Genetic Predictors of Efficiency and Safety of ICIs in Patients With Different Malignancies (ICIPRESIST-0519) · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03574753Phase 2 · completed Lung-MAP S1400K: c-MET Positive · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05024266Phase 2 · unknown Tislelizumab Combined With Chemotherapy as Neoadjuvant Therapy for Stage IIIA-IIIB (N2) Lung Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05010330unknown Identify Prognostic Biomarkers of Lung Cancer · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04846452Phase 2 · unknown Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03377556Phase 2 · completed Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02785939Phase 2/Phase 3 · completed Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02965378Phase 2/Phase 3 · completed Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01958372Phase 1 · completed Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04267913Phase 2 · withdrawn Testing of TAK228 (MLN0128, Sapanisertib) Plus Docetaxel to the Usual Standard of Care for Advanced Squamous Cell Lung Cancer (A Lung-MAP Treatment Trial) · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02785913Phase 2 · completed Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01784640Phase 1 · completed Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01383668Phase 1 · withdrawn Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03823625Phase 2 · unknown An Open-label, Randomized, Parallel, Non Comparative, Phase II Trial of Nivolumab Plus Ipilimumab Versus Platinum-based Chemotherapy Plus Nivolumab in Chemonaive Metastatic or Recurrent Squamous-Cell Lung Cancer (SqLC) · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02926638Phase 2/Phase 3 · terminated Lung-MAP: Rilotumumab and Erlotinib Hydrochloride or Erlotinib Hydrochloride Alone as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03574818Phase 2 · terminated Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001 · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04306042unknown A Survival Observational Study in Patients With Advanced IIIB-IV Squamous Cell Lung Cancer Receiving PD-1 Combination With Chemotherapy · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02583542Phase 1/Phase 2 · unknown A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced Cancers · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03059641completed Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy of NSCLC Patients in China · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03811652Phase 1 · completed A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Non-Small Cell Squamous Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04132102Phase 4 · unknown To Evaluate the Efficacy of Afatinib in Advanced Lung Squamous Cell Carcinoma With EGFR Sensitive Mutation · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02713828Phase 1/Phase 2 · terminated Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03938012unknown Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00784329NA · withdrawn Pilot Study To Evaluate Optical Frequency Domain Imaging For Diagnosis Of Central Airway Disease · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03346304Phase 2/Phase 3 · withdrawn Photodynamic Therapy for the Prevention of Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03725423Phase 4 · unknown Apatinib for Advanced Lung Squmamous Carcinoma · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01557959Phase 2 · completed Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01396603completed Pilot Study to Evaluate Optical Frequency Domain Imaging for Diagnosis of Central Airway Disease · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02852083Phase 2 · unknown A Trial With Metronomic Low-dose Treosulfan, Pioglitazone and Clarithromycin Versus Standard Treatment in NSCLC · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02423590Phase 2 · unknown Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01807546Phase 2 · completed Oral Rigosertib for Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01948141Phase 2 · completed Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01726296NA · completed Adherence to Survivorship Care Guidelines in Health Care Providers for Non-Small Cell Lung Cancer and Colorectal Cancer Survivor Care · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01294306Phase 2 · completed MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02787473Phase 2 · unknown A Study of Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Docetaxel Consolidation in Patients With Inoperable Squamous Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02876978Phase 1 · unknown Anti-GPC3 CAR T for Recurrent or Refractory Lung Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01115790Phase 1 · completed A Phase 1 Study in Participants With Advanced Cancer · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01082549Phase 3 · completed Trial of Gemcitabine/Carboplatin With or Without Iniparib (SAR240550) (a PARP1 Inhibitor) in Subjects With Previously Untreated Stage IV Squamous Non-Small-Cell Lung Cancer (NSCLC) · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01801852NA · unknown Autologous Natural Killer T Cells Infusion for the Treatment of Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01660399Phase 2 · unknown Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02536495Phase 1/Phase 2 · withdrawn Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung Cancer · condition mapped CURATED_BROADER · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00368992Phase 2 · completed S0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02059967Phase 1 · withdrawn Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02009605Phase 2 · unknown Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049543Phase 3 · completed Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02288026unknown Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01668823Phase 1 · completed Photodynamic Therapy in Treating Patients With Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01491633Phase 2 · terminated Dasatinib in Advanced Squamous Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01969955Phase 2 · unknown Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01947062Phase 3 · unknown Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcinoma · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002852Phase 3 · completed Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00040794Phase 2 · completed Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00118183Phase 2 · completed Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01795768Phase 2 · unknown Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087412Phase 2 · completed S0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00020709Phase 3 · completed Combination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00042835Phase 1 · terminated Erlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III Non-Small Cell Lung Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005838Phase 3 · completed Combination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed By Surgery · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00387374Phase 2 · completed Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00909558Phase 1 · suspended Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer · condition mapped ALIAS · 141 trials mapped (43 active) | — | — | Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |